Tirzepatide

ABOUT THIS COMPOUND

Tirzepatide (10mg) is held in stock at Klow Peptide for Australian laboratories running controlled in-vitro work. The compound appears throughout biochemical and cell-based literature, and researchers choose it for its stability, repeatable behaviour and verified identity. Every Tirzepatide vial is produced through solid-phase synthesis in accredited facilities, then lot-tested by an independent laboratory for purity and composition. It arrives as 10mg of freeze-dried powder — a dependable metabolic research peptides reference material for documented research.

HIGHLIGHTS

• 10mg of freeze-dried powder in each vial
• Independently confirmed purity of 99.78% by HPLC-MS
• Research-grade Tirzepatide with lot-level traceability
• Produced in accredited, quality-audited facilities
• Sealed vial with tamper-evident cap
• Tracked, plain-packaged delivery across Australia

PRODUCT DETAILS

Item

Tirzepatide

Amount

10mg per vial

Purity

99.78% (HPLC-MS)

Grade

Research use

Form

Freeze-dried (lyophilised) powder

Appearance

White to off-white solid

Packaging

Sealed, tamper-evident vial

Storage

Keep cool and dry; refrigerate for extended storage

THE KLOW PEPTIDE STANDARD

Klow Peptide is an Australian-run research supplier focused on documented quality. Each Tirzepatide lot is assessed by HPLC-MS before release, and the results are tied to a batch number you can check against our published certificates. Paid orders leave our Australian facility the same business day via Australia Post Express in plain packaging.